Clinical Trial to Investigate the Efficacy and Safety of NuSepin ® in COVID-19 Pneumonia Patients
Conditions: Covid19; Pneumonia Interventions: Drug: NuSepin® 0.1 mg; Drug: NuSepin® 0.2 mg; Drug: Placebo Sponsor: Shaperon Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials